Bulk drug units may not have to assess environment impact

The ministry of environment and forest is contemplating putting bulk drug manufacturing units in B2 category, which would mean that their manufacturers will not be required to submit an environment impact assessment (EIA) report.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2IJEpbM
via IFTTT